The majority of the variants were associated with hepatic lipid metabolism and fatty liver disease, with certain variants (in APOE and TRIB1) displaying significantly larger effects on NAFLD compared with cirrhosis. This evidence concerns the gene TRIB1 and metabolic dysfunction-associated steatotic liver disease.